Literature DB >> 25072014

Diffusion-weighted imaging of skull lesions.

Daniel T Ginat1, Rajiv Mangla2, Gabrielle Yeaney3, Sven Ekholm2.   

Abstract

Diffusion-weighted imaging can increase the conspicuity of skull lesions and be applied toward noninvasive differentiation of malignant from benign lesions. Malignant skull lesions generally display lower diffusivity than benign lesions, although there are exceptions, and clinical parameters and conventional imaging modalities should also be considered in the evaluation of skull lesions. Nevertheless, in some instances diffusion-weighted imaging (DWI) can be used for problem solving when conventional imaging features are indeterminate, such as with skull base involvement by nasopharyngeal carcinoma versus osteomyelitis. In addition, DWI may be useful for monitoring treatment effects. The use of readout segmented technique, parallel imaging, multishot acquisition, turbo spin-echo DWI, diffusion tensor imaging, and higher field strengths can improve image quality. The feasibility of implementing DWI for characterizing skull lesions, the DWI findings of benign and malignant skull lesions, and technical considerations are discussed in this article.

Entities:  

Keywords:  MRI; apparent diffusion coefficient; diffusion-weighted imaging; lesions; skull

Year:  2014        PMID: 25072014      PMCID: PMC4078190          DOI: 10.1055/s-0034-1371362

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  39 in total

1.  Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density.

Authors:  Daniel T Ginat; Rajiv Mangla; Gabrielle Yeaney; Mahlon Johnson; Sven Ekholm
Journal:  AJR Am J Roentgenol       Date:  2012-06       Impact factor: 3.959

2.  Diffusion MR imaging features of skull base osteomyelitis compared with skull base malignancy.

Authors:  B Ozgen; K K Oguz; A Cila
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

3.  Cranial Ewing's sarcoma in children.

Authors:  Maria Moschovi; George A Alexiou; Natalia Tourkantoni; Mirsini-Ersi Balafouta; Christos Antypas; Maria Tsiotra; George Sfakianos; Neofytos Prodromou
Journal:  Neurol Sci       Date:  2011-03-02       Impact factor: 3.307

4.  Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging.

Authors:  S Chen; F Ikawa; K Kurisu; K Arita; J Takaba; Y Kanou
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

5.  Detection of middle ear cholesteatoma by diffusion-weighted MR imaging: multishot echo-planar imaging compared with single-shot echo-planar imaging.

Authors:  K Yamashita; T Yoshiura; A Hiwatashi; H Kamano; T Dashjamts; S Shibata; A Tamae; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-21       Impact factor: 3.825

6.  Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.

Authors:  Christopher J Hanrahan; Carl R Christensen; Julia R Crim
Journal:  Radiographics       Date:  2010-01       Impact factor: 5.333

7.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; Christoph Becker; Stefan Oswald Schoenberg; Nicola Lang; Reiner Bartl; Maximilian Ferdinand Reiser
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

8.  Nasopharyngeal carcinoma: CT evaluation of patterns of tumor spread.

Authors:  J S Sham; Y K Cheung; D Choy; F L Chan; L Leong
Journal:  AJNR Am J Neuroradiol       Date:  1991 Mar-Apr       Impact factor: 3.825

9.  The investigation of the recurrence rate of cholesteatoma using Kaplan-Meier survival analysis.

Authors:  Yasuo Mishiro; Masafumi Sakagami; Tadashi Kitahara; Kazumasa Kondoh; Shin-ichi Okumura
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

10.  Evaluation of diffusion-weighted imaging for the differential diagnosis of poorly contrast-enhanced and T2-prolonged bone masses: Initial experience.

Authors:  Yoshiko Hayashida; Toshinori Hirai; Toshitake Yakushiji; Kazuhiro Katahira; Osamu Shimomura; Masanori Imuta; Takeshi Nakaura; Daisuke Utsunomiya; Kazuo Awai; Yasuyuki Yamashita
Journal:  J Magn Reson Imaging       Date:  2006-03       Impact factor: 4.813

View more
  6 in total

Review 1.  Role of diffusion-weighted imaging in head and neck lesions: Pictorial review.

Authors:  Neeraj Bhatt; Nishant Gupta; Neetu Soni; Kusum Hooda; Joshua M Sapire; Yogesh Kumar
Journal:  Neuroradiol J       Date:  2017-06-19

Review 2.  A practical overview of CT and MRI features of developmental, inflammatory, and neoplastic lesions of the sphenoid body and clivus.

Authors:  Cosimo Nardi; Davide Maraghelli; Michele Pietragalla; Elisa Scola; Luca Giovanni Locatello; Giandomenico Maggiore; Oreste Gallo; Maurizio Bartolucci
Journal:  Neuroradiology       Date:  2022-06-03       Impact factor: 2.995

3.  Imaging of skull base tumours.

Authors:  Stefanie Catherine Thust; Tarek Yousry
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-02

Review 4.  White matter tractography for neurosurgical planning: A topography-based review of the current state of the art.

Authors:  Walid I Essayed; Fan Zhang; Prashin Unadkat; G Rees Cosgrove; Alexandra J Golby; Lauren J O'Donnell
Journal:  Neuroimage Clin       Date:  2017-06-15       Impact factor: 4.881

5.  Clinical-radiological-pathological correlation of cavernous sinus hemangioma: Incremental value of diffusion-weighted imaging.

Authors:  Abhishek Mahajan; Vedula Rajni Kanth Rao; Gudipati Anantaram; Ashwin M Polnaya; Sandeep Desai; Paresh Desai; Rammohan Vadapalli; Manas Panigrahi
Journal:  World J Radiol       Date:  2017-08-28

6.  The routes of infection spread in central skull-base osteomyelitis and the diagnostic role of CT and MRI scans.

Authors:  J Mejzlik; M Cerny; L Zeinerova; J Dedkova; J Kopriva; K Zadrobilek; J Adamkov; V Chrobok; V Pellantova
Journal:  BMC Med Imaging       Date:  2019-08-01       Impact factor: 1.930

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.